Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines

Oncogene

Volumn 23, Issue 4, 2004, Pages 1010-1013

  Kauraniemi, Päivikki ^a   Hautaniemi, Sampsa ^a   Autio, Reija ^a   Astola, Jaakko ^a   Monni, Outi ^b   Elkahloun, Abdel ^c   Kallioniemi, Anne ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Amplification; Breast cancer; cDNA microarray; HER2; Herceptin

Indexed keywords

DNA; RNA; TRASTUZUMAB;

ALGORITHM; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL ADHESION; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; DRUG EFFECT; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE C FOS; PRIORITY JOURNAL; RNA PROCESSING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS;

EID: 1342322682     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207200     Document Type: Article

References (27)

1. Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC and Norton L. (1996). J. Clin. Oncol., 14, 737-744.
2. Bolstad B, Irizarry R, Astrand M and Speed TA. (2003). Bioinformatics, 19, 185-193.
3. Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME and Shepard HM. (1992). Proc. Natl. Acad. Sci. USA, 89, 4285-4289.
4. Chen Y, Dougherty ER and Bittner ML. (1997). J. Biomed. Optics, 2, 364-374.
5. Cleveland W. (1979). J. Am. Stat. Assoc., 74, 829-836.
6. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G and Slamon DJ. (1999). J. Clin. Oncol., 17, 2639-2648.
7. Duan R, Xie W, Li X, McDougal A and Safe S. (2002). Biochem. Biophys. Res. Commun., 294, 384-394.
8. Eisen M, Spellman P, Brown P and Botstein D. (1998). Proc. Natl. Acad. Sci. USA, 95, 14863-14868.
9. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y and Kanakura Y. (1993). J. Clin. Invest., 92, 1736-1744.
10. Hautaniemi S, Kauraniemi P, Rämö P, Yli-Harja O, Astola J and Kallioniemi A. (2003a). A Strategy for Identifying Class-Separating Genes in Drug-Treatment Microarray Data. Report 1. Institute of Signal Processing, Tampere University of Technology: Finland, ISBN 952-15-1067-6.
11. Hautaniemi S, Yli-Harja O, Astola J, Kauraniemi P, Kallioniemi A, Wolf M, Ruiz J, Mousses S and Kallioniemi O-P. (2003b). Mach. Learn., 52, 45-66.
12. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y and Kitamura Y. (1998). Science, 279, 577-580.
13. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP and Kallioniemi A. (2002). Cancer Res., 62, 6240-6245.
14. Kauraniemi P, Bärlund M, Monni O and Kallioniemi A. (2001). Cancer Res., 61, 8235-8240.
15. Kohonen T (ed). (2001). Self-Organizing Maps, 3rd edn Springer: Heidelberg, Germany.
16. Longley BJ, Reguera MJ and Ma Y. (2001). Leuk. Res., 25, 571-576.
17. Molina MA, Codony-Servat J, Albanell J, Rojo F, Arribas J and Baselga J. (2001). Cancer Res., 61, 4744-4749.
18. Monni O, Bärlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML and Kallioniemi A. (2001). Proc. Natl. Acad. Sci. USA, 98, 5711-5716.
19. Mousses S, Bittner ML, Chen Y, Dougherty ER, Baxevanis A, Meltzer PS and Trent JM. (2000). Functional Genomics: Gene Expression Analysis by cDNA Microarrays, Livesey FJ and Hunt SP (eds). Oxford University Press: Oxford, pp. 113-137.
20. Ross JS and Fletcher JA. (1999). Semin. Cancer Biol., 9, 125-138.
21. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J and Norton L. (2001). N. Engl. J. Med., 344, 783-792.
22. van der Burg B, van Selm-Miltenburg AJ, de Laat SW and van Zoelen EJ. (1989). Mol. Cell. Endocrinol., 64, 223-228.
23. Vesanto J, Himberg J, Alhoniemi E and Parhankangas J. (2000). SOM Toolbox for Matlab 5. Technical Report A57. Helsinki University of Technology: Finland.
24. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ and Press M. (2002). J. Clin. Oncol., 20, 719-726.
25. Wilding G, Lippman ME and Gelmann EP. (1988). Cancer Res., 48, 802-805.
26. Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S and Arteaga CL. (2002). Cancer Res., 62, 4132-4141.
27. Yang Y, Dudoit S, Luu P and Speed T. (2001). Microarrays: Optical Technologies and Informatics, Bittner M, Chen Y, Dorsel A and Dougherty E (eds). SPIE, Society for Optical Engineering: San Jose, CA, pp. 141-152.